- You are here:
- Home »
- Blog »
- colon cancer »
- AHCC and Colorectal Cancer
AHCC and Colorectal Cancer
AHCC and Colorectal Cancer: What the Evidence Shows- Active Hexose Correlated Compound (AHCC) is a mushroom-derived supplement that has been studied for immune support and possible anti-cancer effects.
Although most research involving AHCC has focused on immune function, viral infections, and liver cancer, scientists have also explored whether AHCC may benefit colorectal cancer patients, particularly in the areas of immune support and treatment tolerance.
This article reviews what current science says about AHCC and colorectal cancer.
I am a long-term survivor of an incurable blood cancer called multiple myeloma. When I discovered that my risk of an MM diagnosis was increased by HPV, I decided to take AHCC in an effort to clear the HPV in my body.
When I was blogging about evidence-based therapies to support cancer patients, I wondered about AHCC and its effect on the side effects of cancer patients undergoing chemotherapy and radiation. Experience has taught me that all cancer patients can benefit from pursuing therapies that can reduce side effects.
Feel free to scroll down the page and post a question or comment. I will reply to you ASAP.
Thanks,
David Emerson
- Cancer Survivor
- Cancer Coach
- Director PeopleBeatingCancer
Use of AHCC to Reduce Chemotherapy Side-Effects.
Why Researchers Study AHCC in Cancer
Cancer therapies can suppress immune function, leaving patients vulnerable to:
- Infections
- Treatment toxicity
- Poor treatment response
Because AHCC may enhance immune activity, researchers have studied it as a supportive therapy during cancer treatment.
Reported immune benefits include:
- Increased natural killer cell activity
- Increased T-cell function
- Improved immune signaling
These effects are the reason AHCC has been investigated across several cancer types.
Evidence from Laboratory Studies
Preclinical research suggests compounds in shiitake mushroom mycelia may influence cancer-related pathways such as:
- Cell apoptosis (programmed cell death)
- Immune activation
- Inflammation regulation
Some laboratory studies have shown that mushroom-derived compounds may inhibit the growth of cancer cells in vitro, including colorectal cancer cells.
However, these findings do not necessarily translate into clinical benefit in humans.
Potential Immune Benefits for Colorectal Cancer Patients
Even though direct studies specifically on colorectal cancer are limited, AHCC has demonstrated immune-modulating effects in human studies.
These include:
- Activation of natural killer cells
- Increased T-cell response
- Improved immune regulation during chronic infections
Because immune function plays a major role in cancer control and recurrence prevention, these effects are of interest to researchers studying complementary therapies in colorectal cancer.
AHCC and Treatment Support
Some clinicians have explored AHCC as a supportive supplement during cancer therapy because it may help:
- Reduce treatment-related fatigue
- Improve immune resilience
- Support recovery after chemotherapy
Patients undergoing colorectal cancer treatment often struggle with:
- Immune suppression
- Inflammation
- Fatigue
Integrative therapies aimed at improving immune function may help address these issues.
However, high-quality clinical trials specifically studying AHCC in colorectal cancer patients are still needed.
Safety and Considerations
AHCC appears to be well tolerated in most clinical studies, with minimal side effects reported.
Still, important considerations include:
- Supplements can interact with chemotherapy drugs
- Dosage varies widely across studies
- Patients should always consult their oncology team
Complementary therapies should be used alongside—not instead of—standard cancer treatments.
The Bottom Line
Research on AHCC suggests it may support immune function and help the body fight infections or tolerate treatment.
For colorectal cancer specifically:
- Evidence is still emerging
- Direct clinical trials are limited
- Immune-support benefits may still be relevant
Potential advantages
- Immune system support (NK cells, T cells)
- May reduce chemotherapy side effects
- Possible anti-tumor activity (preclinical)
- Generally well tolerated
Potential concerns
- Possible increase in aromatase activity (estrogen production)
- Possible interaction with endocrine therapy
- Limited breast-cancer–specific clinical trials
- Supplement quality variability
Future research will help clarify whether AHCC can play a meaningful role in colorectal cancer care.
Research References
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6435520/
- https://pubmed.ncbi.nlm.nih.gov/35814366/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9256908/
- AHCC and Colorectal Cancer AHCC and Colorectal Cancer
To Learn More About Complementary Therapies